Skip to main content
Top
Published in: Clinical Rheumatology 1/2018

01-01-2018 | Original Article

Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus

Authors: Xing Zhen Liu, Ying Gao, Jie Fan, Xia Xu, Ju Zhang, Jie Gao, Wei Wan, Dong Bao Zhao

Published in: Clinical Rheumatology | Issue 1/2018

Login to get access

Abstract

The metabolic characteristics of rheumatoid arthritis (RA) or diabetes mellitus (DM) have been studied, but the metabolic abnormalities of RA patients complicated with DM are not completely understood. Therefore, we recruited RA patients with DM to investigate the metabolic abnormalities in these patients. We collected data of RA patients with DM and age- and sex-matched RA and DM patients from Changhai Hospital’s electronic medical record system. Data of demographically matched healthy controls were also collected from the health management system of the Hangzhou Sanatorium of People’s Liberation Army. Blood pressure, uric acid, glucose, and lipid levels were compared. The clinical data of RA with DM (n = 104), DM (n = 100), and RA (n = 100) patients and healthy controls (n = 100) were collected and compared. RA patients with DM had higher blood pressure and lower high-density lipoprotein cholesterol levels than the other three groups, a higher triglycerides (TG) level than healthy controls and RA patients, and a lower TG level than DM patients. RA patients with DM exhibited a relatively high proportion of metabolic abnormalities based on existing standards. Our study examined metabolic abnormalities in RA patients with DM for the first time, and our results suggest that clinicians should pay more attention to the metabolic abnormalities of RA patients with DM.
Literature
1.
go back to reference Liu XZ, Fan J, Qi K, Liu SP, Xu WD, Gao Y, Gu XD, Li J, Bai CG, Shi YQ, Zhang LL, Zhao DB (2017) Dishevelled2 promotes apoptosis and inhibits inflammatory cytokine secretion in rheumatoid arthritis fibroblast-like synoviocytes through crosstalk with the NF-κB pathway. Oncotarget 8:12649–12663PubMedPubMedCentral Liu XZ, Fan J, Qi K, Liu SP, Xu WD, Gao Y, Gu XD, Li J, Bai CG, Shi YQ, Zhang LL, Zhao DB (2017) Dishevelled2 promotes apoptosis and inhibits inflammatory cytokine secretion in rheumatoid arthritis fibroblast-like synoviocytes through crosstalk with the NF-κB pathway. Oncotarget 8:12649–12663PubMedPubMedCentral
2.
go back to reference Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697CrossRefPubMed Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697CrossRefPubMed
3.
go back to reference Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732CrossRefPubMed Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732CrossRefPubMed
4.
go back to reference Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303–1307CrossRefPubMed Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303–1307CrossRefPubMed
5.
go back to reference Amaya-Amaya J, Sarmiento-Monroy JC, Mantilla RD, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM (2013) Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol Res 56:267–286CrossRefPubMed Amaya-Amaya J, Sarmiento-Monroy JC, Mantilla RD, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM (2013) Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol Res 56:267–286CrossRefPubMed
6.
go back to reference Wibetoe G, Ikdahl E, Rollefstad S, Olsen IC, Bergsmark K, Kvien TK, Salberg A, Soldal DM, Bakland G, Lexberg Å, Fevang BT, Gulseth HC, Haugeberg G, Semb AG (2017) Cardiovascular disease risk profiles in inflammatory joint disease entities. Arthritis Res Ther 19:153CrossRefPubMedPubMedCentral Wibetoe G, Ikdahl E, Rollefstad S, Olsen IC, Bergsmark K, Kvien TK, Salberg A, Soldal DM, Bakland G, Lexberg Å, Fevang BT, Gulseth HC, Haugeberg G, Semb AG (2017) Cardiovascular disease risk profiles in inflammatory joint disease entities. Arthritis Res Ther 19:153CrossRefPubMedPubMedCentral
7.
go back to reference Solomon DH, Love TJ, Canning C, Schneeweiss S (2010) Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 69:2114–2117CrossRefPubMedPubMedCentral Solomon DH, Love TJ, Canning C, Schneeweiss S (2010) Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 69:2114–2117CrossRefPubMedPubMedCentral
8.
go back to reference Barber CE, Smith A, Esdaile JM, Barnabe C, Martin LO, Faris P, Hazlewood G, Noormohamed R, Alvarez N, Mancini GB, Lacaille D, Keeling S, Aviña-Zubieta JA, Marshall D (2015) Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators. Arthritis Care Res (Hoboken) 67:169–179CrossRef Barber CE, Smith A, Esdaile JM, Barnabe C, Martin LO, Faris P, Hazlewood G, Noormohamed R, Alvarez N, Mancini GB, Lacaille D, Keeling S, Aviña-Zubieta JA, Marshall D (2015) Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators. Arthritis Care Res (Hoboken) 67:169–179CrossRef
9.
go back to reference Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76:17–28CrossRefPubMed Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76:17–28CrossRefPubMed
10.
go back to reference Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C, Mu Y, Hao C, Ji Q, Ran X, Su B, Zhuo H, Fox KA, Weber M, Zhang D, CCMR Advisory Board, CCMR-3B STUDY Investigators (2013) Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med 126:925.e11–925.e22CrossRef Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C, Mu Y, Hao C, Ji Q, Ran X, Su B, Zhuo H, Fox KA, Weber M, Zhang D, CCMR Advisory Board, CCMR-3B STUDY Investigators (2013) Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med 126:925.e11–925.e22CrossRef
11.
go back to reference Bartels CM, Kind AJ, Thorpe CT, Everett CM, Cook RJ, McBride PE, Smith MA (2012) Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a medicare analysis. Semin Arthritis Rheum 42:9–16CrossRefPubMedPubMedCentral Bartels CM, Kind AJ, Thorpe CT, Everett CM, Cook RJ, McBride PE, Smith MA (2012) Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a medicare analysis. Semin Arthritis Rheum 42:9–16CrossRefPubMedPubMedCentral
12.
go back to reference Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101CrossRefPubMed
13.
go back to reference van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, Stehouwer CD, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Smulders YM, Dijkmans BA, Nurmohamed MT (2009) Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 68:1395–1400CrossRefPubMed van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, Stehouwer CD, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Smulders YM, Dijkmans BA, Nurmohamed MT (2009) Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 68:1395–1400CrossRefPubMed
14.
go back to reference Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, Visser M, Stehouwer CD, Dekker JM, Nijpels G, Heine R, Dijkmans BA (2009) Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 61:1571–1579CrossRefPubMed Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, Visser M, Stehouwer CD, Dekker JM, Nijpels G, Heine R, Dijkmans BA (2009) Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 61:1571–1579CrossRefPubMed
15.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
16.
go back to reference Graf J, Scherzer R, Grunfeld C, Imboden J (2009) Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. PLoS One 4:e6242CrossRefPubMedPubMedCentral Graf J, Scherzer R, Grunfeld C, Imboden J (2009) Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. PLoS One 4:e6242CrossRefPubMedPubMedCentral
17.
go back to reference McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, Capell HA, Sattar N (2004) Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 363:2015–2021CrossRefPubMed McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, Capell HA, Sattar N (2004) Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 363:2015–2021CrossRefPubMed
18.
go back to reference Expert Consultation WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef Expert Consultation WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef
19.
go back to reference Innala L, Möller B, Ljung L, Magnusson S, Smedby T, Södergren A, Öhman ML, Rantapää-Dahlqvist S, Wållberg-Jonsson S (2011) Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 13:R131CrossRefPubMedPubMedCentral Innala L, Möller B, Ljung L, Magnusson S, Smedby T, Södergren A, Öhman ML, Rantapää-Dahlqvist S, Wållberg-Jonsson S (2011) Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 13:R131CrossRefPubMedPubMedCentral
20.
go back to reference Gabriel SE, Crowson CS (2012) Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 24:171–176CrossRefPubMed Gabriel SE, Crowson CS (2012) Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 24:171–176CrossRefPubMed
21.
go back to reference Chinese adult dyslipidemia Prevention Guide Revision Joint Committee (2016) Chinese adult dyslipidemia prevention guide (2016 revised edition). Chinese Circulation Journal 31:937–953 (In Chinese) Chinese adult dyslipidemia Prevention Guide Revision Joint Committee (2016) Chinese adult dyslipidemia prevention guide (2016 revised edition). Chinese Circulation Journal 31:937–953 (In Chinese)
22.
go back to reference Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed
23.
go back to reference Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW (2004) Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 50:3444–3449CrossRefPubMed Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW (2004) Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 50:3444–3449CrossRefPubMed
24.
go back to reference Ljung L, Rantapää-Dahlqvist S (2016) Abdominal obesity, gender and the risk of rheumatoid arthritis—a nested case-control study. Arthritis Res Ther 18:277CrossRefPubMedPubMedCentral Ljung L, Rantapää-Dahlqvist S (2016) Abdominal obesity, gender and the risk of rheumatoid arthritis—a nested case-control study. Arthritis Res Ther 18:277CrossRefPubMedPubMedCentral
25.
go back to reference Tedeschi SK, Cui J, Arkema EV, Robinson WH, Sokolove J, Lingampalli N, Sparks JA, Karlson EW, Costenbader KH (2016) Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: a nested case-control study of women in the Nurses’ Health Studies. Semin Arthritis Rheum S0049-0172:30268–30262 Tedeschi SK, Cui J, Arkema EV, Robinson WH, Sokolove J, Lingampalli N, Sparks JA, Karlson EW, Costenbader KH (2016) Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: a nested case-control study of women in the Nurses’ Health Studies. Semin Arthritis Rheum S0049-0172:30268–30262
26.
go back to reference Unriza-Puin S, Bautista-Molano W, Lafaurie GI, Valle-Oñate R, Chalem P, Chila-Moreno L, Bello-Gualtero JM, Romero-Sánchez C (2016) Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives? Clin Rheumatol [Epub ahead of print] Unriza-Puin S, Bautista-Molano W, Lafaurie GI, Valle-Oñate R, Chalem P, Chila-Moreno L, Bello-Gualtero JM, Romero-Sánchez C (2016) Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives? Clin Rheumatol [Epub ahead of print]
27.
go back to reference Albrecht K, Richter A, Callhoff J, Huscher D, Schett G, Strangfeld A, Zink A (2016) Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases. Arthritis Res Ther 18:149CrossRefPubMedPubMedCentral Albrecht K, Richter A, Callhoff J, Huscher D, Schett G, Strangfeld A, Zink A (2016) Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases. Arthritis Res Ther 18:149CrossRefPubMedPubMedCentral
28.
go back to reference Du T, Sun X, Yin P, Huo R, Ni C, Yu X (2013) Increasing trends in central obesity among Chinese adults with normal body mass index, 1993-2009. BMC Public Health 13:327CrossRefPubMedPubMedCentral Du T, Sun X, Yin P, Huo R, Ni C, Yu X (2013) Increasing trends in central obesity among Chinese adults with normal body mass index, 1993-2009. BMC Public Health 13:327CrossRefPubMedPubMedCentral
29.
go back to reference Kahn HS, Bullard KM (2016) Beyond body mass index: advantages of abdominal measurements for recognizing cardiometabolic disorders. Am J Med 129:74–81.e2CrossRefPubMed Kahn HS, Bullard KM (2016) Beyond body mass index: advantages of abdominal measurements for recognizing cardiometabolic disorders. Am J Med 129:74–81.e2CrossRefPubMed
30.
go back to reference Savva SC, Lamnisos D, Kafatos AG (2013) Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes 6:403–419CrossRefPubMedPubMedCentral Savva SC, Lamnisos D, Kafatos AG (2013) Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes 6:403–419CrossRefPubMedPubMedCentral
31.
32.
go back to reference Kellner H, Bornholdt K, Hein G (2010) Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study. Clin Rheumatol 29:913–920CrossRefPubMedPubMedCentral Kellner H, Bornholdt K, Hein G (2010) Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study. Clin Rheumatol 29:913–920CrossRefPubMedPubMedCentral
33.
go back to reference Protogerou AD, Panagiotakos DB, Zampeli E, Argyris AA, Arida K, Konstantonis GD, Pitsavos C, Kitas GD, Sfikakis PP (2013) Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon. Arthritis Res Ther 15:R142CrossRefPubMedPubMedCentral Protogerou AD, Panagiotakos DB, Zampeli E, Argyris AA, Arida K, Konstantonis GD, Pitsavos C, Kitas GD, Sfikakis PP (2013) Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon. Arthritis Res Ther 15:R142CrossRefPubMedPubMedCentral
34.
go back to reference Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE, Huizinga TW, van de Stadt RJ, Dijkmans BA, van der Linden S (2003) Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 62:842–845CrossRefPubMedPubMedCentral Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE, Huizinga TW, van de Stadt RJ, Dijkmans BA, van der Linden S (2003) Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 62:842–845CrossRefPubMedPubMedCentral
35.
go back to reference Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11:693–704CrossRefPubMed Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11:693–704CrossRefPubMed
36.
go back to reference Toms TE, Panoulas VF, Douglas KM, Nightingale P, Smith JP, Griffiths H, Sattar N, Symmons DP, Kitas GD (2011) Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? Angiology 62:167–175CrossRefPubMed Toms TE, Panoulas VF, Douglas KM, Nightingale P, Smith JP, Griffiths H, Sattar N, Symmons DP, Kitas GD (2011) Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? Angiology 62:167–175CrossRefPubMed
37.
go back to reference Pérez de Isla L; SEC Working Group for the 2016 ESC Guidelines for the Management of Dyslipidemias:, Pérez de Isla L, Fernández PL, Álvarez-Sala Walther L, Barrios Alonso V, Castro Conde A, Galve Basilio E, García Ortiz L, Mata López P; Expert Reviewers for the 2016 ESC Guidelines for the Management of Dyslipidemias:, Alegría Ezquerra E, Cordero Fort A, Cosin Sales J, Escobar Cervantes C, García-Moll Marimón X, José Gómez Doblas J, Marzal Martín D, Murga Eizagaechevarria N, de Pablo Zarzosa C, Miguel Rincón L, Sanchis Forés J; SEC Guidelines Committee:, Alberto San Román Calvar J, Alfonso Manterola F, Arribas Ynsaurriaga F, Evangelista Masip A, Ferreira González I, Jiménez Navarro M, Marín Ortuño F, Pérez de Isla L, Rodríguez Padial L, Luis Sánchez Fernández P, Sionis Green A, Vázquez García R (2017) Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias. Rev Esp Cardiol (Engl Ed) 70:72–77 Pérez de Isla L; SEC Working Group for the 2016 ESC Guidelines for the Management of Dyslipidemias:, Pérez de Isla L, Fernández PL, Álvarez-Sala Walther L, Barrios Alonso V, Castro Conde A, Galve Basilio E, García Ortiz L, Mata López P; Expert Reviewers for the 2016 ESC Guidelines for the Management of Dyslipidemias:, Alegría Ezquerra E, Cordero Fort A, Cosin Sales J, Escobar Cervantes C, García-Moll Marimón X, José Gómez Doblas J, Marzal Martín D, Murga Eizagaechevarria N, de Pablo Zarzosa C, Miguel Rincón L, Sanchis Forés J; SEC Guidelines Committee:, Alberto San Román Calvar J, Alfonso Manterola F, Arribas Ynsaurriaga F, Evangelista Masip A, Ferreira González I, Jiménez Navarro M, Marín Ortuño F, Pérez de Isla L, Rodríguez Padial L, Luis Sánchez Fernández P, Sionis Green A, Vázquez García R (2017) Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias. Rev Esp Cardiol (Engl Ed) 70:72–77
38.
go back to reference van den Oever IAM, Heslinga M, Griep EN, Griep-Wentink HRM, Schotsman R, Cambach W, Dijkmans BAC, Smulders YM, Lems WF, Boers M, Voskuyl EA, Peters MJL, van Schaardenburg D, Nurmohamed MT (2017) Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project. Rheumatology van den Oever IAM, Heslinga M, Griep EN, Griep-Wentink HRM, Schotsman R, Cambach W, Dijkmans BAC, Smulders YM, Lems WF, Boers M, Voskuyl EA, Peters MJL, van Schaardenburg D, Nurmohamed MT (2017) Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project. Rheumatology
39.
go back to reference Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE (2012) Usefulness of Risk Scores to Estimate the Risk of Cardiovascular Disease in Patients With Rheumatoid Arthritis. The American Journal of Cardiology 110(3):420–424 Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE (2012) Usefulness of Risk Scores to Estimate the Risk of Cardiovascular Disease in Patients With Rheumatoid Arthritis. The American Journal of Cardiology 110(3):420–424
40.
go back to reference Arts EEA, Popa C, Den Broeder AA, Semb AG, Toms T, Kitas GD, van Riel PL, Fransen J (2015) Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases 74(4):668–674 Arts EEA, Popa C, Den Broeder AA, Semb AG, Toms T, Kitas GD, van Riel PL, Fransen J (2015) Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases 74(4):668–674
Metadata
Title
Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus
Authors
Xing Zhen Liu
Ying Gao
Jie Fan
Xia Xu
Ju Zhang
Jie Gao
Wei Wan
Dong Bao Zhao
Publication date
01-01-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3847-7

Other articles of this Issue 1/2018

Clinical Rheumatology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine